A way forward is an opportunity to avoid the pitfalls of previous processes

September 20, 2024 Latest News BioPharma Comment

This is a preview of subscriber content

Subscribe now to continue reading.

Get this right, and the industry and other stakeholders can embark on the implementation process from a more favourable starting point of pursuing the opportunities while adequately understanding the risks. …

Subscribe now to continue reading.

Latest Video

The lesson to learn from the Guild is that you cannot defeat what you do not know
December 14, 2025 - Latest News
Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis
December 15, 2025 - Latest News
Algorae unveils major breakthrough in AI-driven drug combination discovery
December 14, 2025 - Australian Biotech
GBMA to host inaugural summit aimed at addressing medicine shortages
December 15, 2025 - Latest News
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - Latest News

A way forward is an opportunity to avoid the pitfalls of previous processes

This is a preview of subscriber content

Latest Video

Most Read

The lesson to learn from the Guild is that you cannot defeat what you do not know

Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis

Algorae unveils major breakthrough in AI-driven drug combination discovery

GBMA to host inaugural summit aimed at addressing medicine shortages

The industry is probably right to resist, it just needs to prepare for the response

New Stories

Island Pharmaceuticals secures key partnership with Texas Biomed

Novartis names new Country President following leadership transition

Mayne Pharma opens expanded manufacturing facility after termination of takeover

Budget update includes impact of listings, but generally not much else

The UK reconfirms the direct impact of the transatlantic shift in medicine pricing

The industry is probably right to resist, it just needs to prepare for the response

Cynata completes patient enrolment in Phase 2 trial for aGvHD therapy

Sign In

A way forward is an opportunity to avoid the pitfalls of previous processes

This is a preview of subscriber content

Latest Video

Most Read

The lesson to learn from the Guild is that you cannot defeat what you do not know

Lilly announces Phase 3 results for triple agonist in obesity and knee osteoarthritis

Algorae unveils major breakthrough in AI-driven drug combination discovery

GBMA to host inaugural summit aimed at addressing medicine shortages

The industry is probably right to resist, it just needs to prepare for the response

Follow Us

New Stories

Island Pharmaceuticals secures key partnership with Texas Biomed

Novartis names new Country President following leadership transition

Mayne Pharma opens expanded manufacturing facility after termination of takeover

Budget update includes impact of listings, but generally not much else

The UK reconfirms the direct impact of the transatlantic shift in medicine pricing

The industry is probably right to resist, it just needs to prepare for the response

Cynata completes patient enrolment in Phase 2 trial for aGvHD therapy